Biosynthetic pathway of GSL and the CIRES procedure
Biosynthetic pathway of GSL and the CIRES procedure. A, biosynthetic pathway for GSLs. Biosynthetic pathways for GSLs comprising various series are illustrated. Arrows indicate specific glycosyltransferase reactions for biosynthesis. Biosynthetic pathways of globo-series (top), lacto series (middle), and ganglio series (bottom) incorporating GSL branching at the glycosyltransferase reaction for GM3Syn/ST3GAL5 (depicted as 3), Lc3Syn/B3GNT5 (6), and CD77Syn/A4GALT (7), respectively. The biosynthesis of these three series of glycans share the same substrate, LacCer. The names of the GSLs that terminate with the indicated sugars are shown below. GM1 and CD77 are epitopes for the B subunit of the cholera toxin and shiga toxin, respectively. B, the general concept of CIRES is illustrated. The main methodology and factors involved in CIRES were previously reported (). Briefly, the glycan expression profile was statistically tested against the expression profiles of glycan-related genes that were obtained by cross-sample comparison of cDNA microarray experiments. The presence of glycan-related genes, which exhibit similar (positively correlated) or dissimilar (negatively correlated) profiles to glycan expression, are listed as candidate(s) responsible genes. Genes exhibiting statistical significance by the Pearson correlation index analyses were then experimentally tested for their ability to change the expression of glycans on the cell surface via gene-transfer experiments.